MoneyWorks4Me

Bharat Parenterals - Quaterly Results

12 Nov 2022 Evaluate
The sales for the September 2022 quarter moved up 35.60% to Rs. 819.00 millions as compared to Rs. 604.00 millions during the corresponding quarter last year.Net profit stood at Rs. 100.00  millions  compared to Rs. 80.20 millions in the corresponding previous quarter,high by 24.69%.Operating Profit saw a handsome growth to 157.40 millions from 126.40 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 819.00 604.00 35.60 1079.90 1212.40 -10.93 2120.10 2036.70 4.09
Other Income 63.90 25.20 153.57 79.30 42.80 85.28 77.80 86.70 -10.27
PBIDT 157.40 126.40 24.53 192.10 251.00 -23.47 359.20 338.10 6.24
Interest 3.40 1.50 126.67 5.90 4.40 34.09 8.90 7.60 17.11
PBDT 154.00 124.90 23.30 186.20 246.60 -24.49 350.30 330.50 5.99
Depreciation 14.50 17.20 -15.70 29.90 34.60 -13.58 66.60 60.30 10.45
PBT 139.50 107.70 29.53 156.30 212.00 -26.27 283.70 270.20 5.00
TAX 39.50 27.50 43.64 43.80 54.20 -19.19 70.70 68.10 3.82
Deferred Tax 1.50 -1.30 -215.38 0.90 -2.60 -134.62 -9.40 -2.80 235.71
PAT 100.00 80.20 24.69 112.50 157.80 -28.71 213.00 202.10 5.39
Equity 57.70 57.30 0.70 57.70 57.30 0.70 57.70 57.30 0.70
PBIDTM(%) 19.22 20.93 -8.16 17.79 20.70 -14.08 16.94 16.60 2.06
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..